SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-000882
Filing Date
2021-04-14
Accepted
2021-04-14 08:48:46
Documents
93
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm 10-Q 696143
2 EX-31.1 lxrp_ex311.htm EX-31.1 10005
3 EX-31.2 lxrp_ex312.htm EX-31.2 9806
4 EX-32.1 lxrp_ex321.htm EX-32.1 5049
5 EX-32.2 lxrp_ex322.htm EX-32.2 4904
12 lxrp_10qimg23.jpg GRAPHIC 1590
  Complete submission text file 0001640334-21-000882.txt   5982253

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lxrp-20210228.xml EX-101.INS 1290713
7 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20210228.xsd EX-101.SCH 98052
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20210228_cal.xml EX-101.CAL 48599
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20210228_def.xml EX-101.DEF 136747
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20210228_lab.xml EX-101.LAB 1003451
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20210228_pre.xml EX-101.PRE 313437
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 21824610
SIC: 2834 Pharmaceutical Preparations